During this webinar, Bob Docherty will demonstrate the impact of the Cambridge Crystallographic Data Centre (CCDC) tools on drug development, from discovery to manufacturing, and their potential to accelerate digital transformation in the pharmaceutical industry. He will also focus on the various phases of the drug development process and explain how CCDC tools can help material scientists in making informed decisions prior to pharmaceutical product design, development, and manufacturing. Additionally, Bob Docherty will highlight the crucial role of solid form informatics and crystallography in ensuring the safety and efficacy of new medicines.
In this webinar, we will demonstrate:
Software tools that are pivotal in reshaping knowledge acquisition throughout different drug development phases, facilitating molecule to medicine acceleration .
Tools employed by global pharmaceutical companies to mitigate risks and address issues related to solid forms during their drug development processes.
The significance of crystallography and informatics in guiding informed decision-making and acting as a catalyst for digital transformation